Author:
BARDHAN D,KUMAR SANJAY,KUMAR SHIV,SINGH R P,HOSAMANI M
Abstract
The present study has quantified the economic impact of control of goat pox disease in India using a vaccine developed against the disease at ICAR-IVRI, applying an economic surplus model. The findings of the study have revealed significant benefits of Goat pox control programme using the vaccine. The potential change in total surplus, as a result of Goat pox control programme was ₹ 2.42 crore/annum. The change in total economic surplus and research and delivery cost were projected from 1999 (year of the start of the project) to 2030 after adjusting for the above adoption pattern. Using a long run discount rate of 7.50%, the benefits were compared to research and delivery cost and the NPV, IRR and BCR were calculated. The NPV, IRR and BCR of Goat pox control programme were ₹ 9.25 billion, 38% and 19: 1, respectively. Sensitivity analysis revealed that the benefits are most sensitive to assumptions regarding lower degree of immunity offered by the vaccine and higher discount rate.
Publisher
Indian Council of Agricultural Research, Directorate of Knowledge Management in Agriculture
Subject
General Veterinary,Animal Science and Zoology
Reference23 articles.
1. The economic and poverty impacts of maize research in West and Central Africa
2. Alston J, Norton G W and Pardey P G. 1995. Science Under Scarcity: Principles and Practice for Agricultural Research Evaluation and Priority Setting. CABI International.
3. Bardhan D, Singh R P, Kumar S, Anandasekaran G and Meraj Mohd. 2017. Impact of vaccine against Peste-des-Petits Ruminants (PPR) in India: An analysis using economic surplus model. Indian Journal of Animal Sciences 87(10): 1176–84.
4. Potential Role of Technology in Increasing Productivity and Income at National Level: A Case of Cell-culture Vaccine against Classical Swine Fever
5. An Outline of Meat Consumption in the Indian Population - A Pilot Review